Development and Empirical Research on a Virtual Simulation Training System for Clinical Nurses Responding to Bioterrorist Attacks
- P (Population): Participants in a clinical nursing training program at a certain university
- I (Intervention): Theoretical instruction + training using a self-developed virtual simulation platform for emergency response to bioterrorism incidents; intervention duration: 4 weeks
- C (Comparison): Traditional in-person training (theoretical lectures + practical exercises)
- O (Outcome): Assessment of nursing staff's biosafety response capabilities using the Clinical Nurse Biosafety Response Scale
Обзор исследования
Статус
Подробное описание
This study aims to validate the effectiveness of a virtual simulation training system for emergency response to bioterrorism incidents in enhancing the biosafety response capabilities of clinical nursing staff. An asynchronous controlled trial was conducted, utilizing two consecutive training sessions for clinical nursing staff at a university; participants in the first session were assigned to the control group, while those in the second session were assigned to the intervention group. The control group received traditional in-person training (combining theoretical instruction with practical exercises), while the intervention group underwent training that combined theoretical instruction with the virtual simulation training platform developed for this study. The intervention duration was 4 weeks for both groups, and assessments were conducted before and after the intervention using the Clinical Nurse Biosafety Response Scale.
Тип исследования
Регистрация (Оцененный)
Фаза
- Непригодный
Контакты и местонахождение
Контакты исследования
- Имя: Ning Zha Ning Zha, graduate degree
- Номер телефона: +84 17599456276
- Электронная почта: 1241332783@qq.com
Критерии участия
Критерии приемлемости
Возраст, подходящий для обучения
Принимает здоровых добровольцев
Полы, имеющие право на обучение
Описание
Inclusion Criteria:
- (1) Possession of a valid nurse practicing license; (2) Clinical work experience of ≥ 1 year; (3) Provision of informed consent and voluntary participation in this study.
Exclusion Criteria:
- （1）Participants who withdrew from the study midway; （2）Those who had participated in similar emergency-rescue-related training recently (within the past 3 months).
Учебный план
Как устроено исследование?
Детали дизайна
- Основная цель: Другой
- Распределение: Нерандомизированный
- Интервенционная модель: Одногрупповое задание
- Маскировка: Нет (открытая этикетка)
Оружие и интервенции
Группа участников / Армия |
Вмешательство/лечение |
|---|---|
|
Плацебо Компаратор: Conventional face-to-face training on emergency response to bioterrorist attacks
The control group received **conventional face-to-face training on emergency response to bioterrorist attacks**, including theoretical lectures and practical drills. |
This study focused on a training program for school nursing staff, with participants from the first cohort serving as the control group and those from the second cohort as the intervention group. A non-concurrent controlled experiment was conducted: the control group received traditional in-person training consisting of theoretical instruction and practical exercises, while the intervention group received training that combined theoretical instruction with a virtual simulation training platform developed for this study. |
|
Активный компаратор: Virtual simulation training for emergency response to bioterrorist attacks
The intervention group received theoretical lectures combined with **virtual simulation training for emergency response to bioterrorist attacks** developed in this study. |
This study focused on a training program for school nursing staff, with participants from the first cohort serving as the control group and those from the second cohort as the intervention group. A non-concurrent controlled experiment was conducted: the control group received traditional in-person training consisting of theoretical instruction and practical exercises, while the intervention group received training that combined theoretical instruction with a virtual simulation training platform developed for this study. |
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Biosafety incident response competence
Временное ограничение: From enrollment to the completion of the four-week training.
|
The training effect among nurses was evaluated using the self-developed biosecurity incident response competence scale of our research group, which covers four dimensions: biosecurity incident monitoring and early-warning competence, nursing management competence for biosecurity incidents, biosecurity knowledge readiness, and biosecurity infection-protection competence. |
From enrollment to the completion of the four-week training.
|
Соавторы и исследователи
Даты записи исследования
Изучение основных дат
Начало исследования (Оцененный)
Первичное завершение (Оцененный)
Завершение исследования (Оцененный)
Даты регистрации исследования
Первый отправленный
Впервые представлено, что соответствует критериям контроля качества
Первый опубликованный (Действительный)
Обновления учебных записей
Последнее опубликованное обновление (Действительный)
Последнее отправленное обновление, отвечающее критериям контроля качества
Последняя проверка
Дополнительная информация
Термины, связанные с этим исследованием
Ключевые слова
Дополнительные соответствующие термины MeSH
Другие идентификационные номера исследования
- K202509-01
Планирование данных отдельных участников (IPD)
Планируете делиться данными об отдельных участниках (IPD)?
Информация о лекарствах и устройствах, исследовательские документы
Изучает лекарственный продукт, регулируемый FDA США.
Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .